| __timestamp | Grifols, S.A. | Pharming Group N.V. |
|---|---|---|
| Wednesday, January 1, 2014 | 180753000 | 14182353 |
| Thursday, January 1, 2015 | 224193000 | 15503028 |
| Friday, January 1, 2016 | 197617000 | 16183585 |
| Sunday, January 1, 2017 | 288320000 | 22382849 |
| Monday, January 1, 2018 | 240661000 | 33038206 |
| Tuesday, January 1, 2019 | 276018000 | 31777040 |
| Wednesday, January 1, 2020 | 294216000 | 41464134 |
| Friday, January 1, 2021 | 354881000 | 67178053 |
| Saturday, January 1, 2022 | 361140000 | 52531000 |
| Sunday, January 1, 2023 | 330551000 | 68914000 |
Data in motion
In the competitive landscape of the pharmaceutical industry, innovation is key. Grifols, S.A. and Pharming Group N.V. have been at the forefront of this race, investing heavily in research and development (R&D) over the past decade. From 2014 to 2023, Grifols consistently outpaced Pharming in R&D spending, with an average annual investment nearly 7.5 times greater. In 2022, Grifols peaked with a 29% increase in R&D expenses compared to 2014, while Pharming showed a remarkable growth of 385% over the same period. This trend highlights Grifols' commitment to maintaining its leadership position, while Pharming's rapid growth underscores its ambition to catch up. As the industry evolves, these investments will likely shape the future of healthcare innovations.
Research and Development: Comparing Key Metrics for Eli Lilly and Company and Grifols, S.A.
R&D Insights: How AstraZeneca PLC and Grifols, S.A. Allocate Funds
BeiGene, Ltd. vs Pharming Group N.V.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Halozyme Therapeutics, Inc. and Pharming Group N.V.
Pharming Group N.V. vs ADMA Biologics, Inc.: Strategic Focus on R&D Spending
Analyzing R&D Budgets: Pharming Group N.V. vs Amneal Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Pharming Group N.V. and Ligand Pharmaceuticals Incorporated
Research and Development Expenses Breakdown: Grifols, S.A. vs TG Therapeutics, Inc.
Analyzing R&D Budgets: Grifols, S.A. vs Amicus Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Grifols, S.A. and PTC Therapeutics, Inc.
Analyzing R&D Budgets: Grifols, S.A. vs Geron Corporation
Analyzing R&D Budgets: Grifols, S.A. vs Xencor, Inc.